Drug Shortage Report for ESOMEPRAZOLE

Last updated on 2021-08-04 History
Report ID 105868
Drug Identification Number 02431173
Brand name ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2020-03-26
Actual start date 2020-03-24
Estimated end date 2021-07-30
Actual end date 2021-08-03
Shortage status Resolved
Updated date 2021-08-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2021-08-04 English Compare
v20 2021-08-03 French Compare
v19 2021-08-03 English Compare
v18 2021-07-05 French Compare
v17 2021-07-05 English Compare
v16 2021-04-28 French Compare
v15 2021-04-28 English Compare
v14 2020-07-08 French Compare
v13 2020-07-08 English Compare
v12 2020-03-25 English Compare
v11 2020-03-24 French Compare
v10 2020-03-24 English Compare
v9 2020-03-24 French Compare
v8 2020-03-24 English Compare
v7 2020-03-10 French Compare
v6 2020-03-10 English Compare
v5 2020-03-10 English Compare
v4 2020-02-26 French Compare
v3 2020-02-26 English Compare
v2 2020-02-12 French Compare

Showing 1 to 20 of 21